Dual Therapeutics
Cleveland
About Dual Therapeutics
Dual Therapeutics is focused on producing therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. Its small-molecule modulators are designed to simultaneously block multiple cancer-promoting pathways, especially those linked to growth and survival, thus allowing a more comprehensive assault on cancer cells without harming healthy cells.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.6M
- Last round: Series Unknown (Jul 2013)
- Website: dualtherapeutics.com
Industries & Categories
Biotechnology, Life Science, Therapeutics
Canonical: https://fsome.com/organization/dual-therapeutics-2187955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.